About Us Services Careers FAQ Contact Us 0
Home Pharmaceuticals Pharmaceutical Analytical Testing Market Size, Share & Trends by 2032
Pharmaceutical Analytical Testing Market

Pharmaceutical Analytical Testing Market Size, Share & Trends Analysis Report By Service Type (Bioanalytical Testing, Method Development and Validation, Stability Testing, Drug Substances Testing, Microbial Testing, Physical Characterization, Others), By End User (Medical Device Companies, Pharmaceutical & Biopharmaceutical Companies, Others) and By Region(North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2024-2032

Report Code: SRPH2585DR
Last Updated : April 01, 2025
Author : Debashree Bora
Starting From
USD 2300
Buy Now
File Formats

Table Of Content

  1. Executive Summary
    1. Research Objectives
    2. Limitations & Assumptions
    3. Market Scope & Segmentation
    4. Currency & Pricing Considered
    1. Emerging Regions / Countries
    2. Emerging Companies
    3. Emerging Applications / End Use
    1. Drivers
    2. Market Warning Factors
    3. Latest Macro Economic Indicators
    4. Geopolitical Impact
    5. Technology Factors
    1. Porters Five Forces Analysis
    2. Value Chain Analysis
    1. North America
    2. Europe
    3. APAC
    4. Middle East and Africa
    5. LATAM
  2. ESG Trends
    1. Global Pharmaceutical Analytical Testing Market Introduction
    2. By Service Type
      1. Introduction
        1. Service Type By Value
      2. Bioanalytical Testing
        1. By Value
      3. Method Development and Validation
        1. By Value
      4. Stability Testing
        1. By Value
      5. Drug Substances Testing
        1. By Value
      6. Microbial Testing
        1. By Value
      7. Physical Characterization
        1. By Value
      8. Others
        1. By Value
    3. By End User
      1. Introduction
        1. End User By Value
      2. Medical Device Companies
        1. By Value
      3. Pharmaceutical & Biopharmaceutical Companies
        1. By Value
      4. Others
        1. By Value
    1. Introduction
    2. By Service Type
      1. Introduction
        1. Service Type By Value
      2. Bioanalytical Testing
        1. By Value
      3. Method Development and Validation
        1. By Value
      4. Stability Testing
        1. By Value
      5. Drug Substances Testing
        1. By Value
      6. Microbial Testing
        1. By Value
      7. Physical Characterization
        1. By Value
      8. Others
        1. By Value
    3. By End User
      1. Introduction
        1. End User By Value
      2. Medical Device Companies
        1. By Value
      3. Pharmaceutical & Biopharmaceutical Companies
        1. By Value
      4. Others
        1. By Value
    4. U.S.
      1. By Service Type
        1. Introduction
          1. Service Type By Value
        2. Bioanalytical Testing
          1. By Value
        3. Method Development and Validation
          1. By Value
        4. Stability Testing
          1. By Value
        5. Drug Substances Testing
          1. By Value
        6. Microbial Testing
          1. By Value
        7. Physical Characterization
          1. By Value
        8. Others
          1. By Value
      2. By End User
        1. Introduction
          1. End User By Value
        2. Medical Device Companies
          1. By Value
        3. Pharmaceutical & Biopharmaceutical Companies
          1. By Value
        4. Others
          1. By Value
    5. Canada
    1. Introduction
    2. By Service Type
      1. Introduction
        1. Service Type By Value
      2. Bioanalytical Testing
        1. By Value
      3. Method Development and Validation
        1. By Value
      4. Stability Testing
        1. By Value
      5. Drug Substances Testing
        1. By Value
      6. Microbial Testing
        1. By Value
      7. Physical Characterization
        1. By Value
      8. Others
        1. By Value
    3. By End User
      1. Introduction
        1. End User By Value
      2. Medical Device Companies
        1. By Value
      3. Pharmaceutical & Biopharmaceutical Companies
        1. By Value
      4. Others
        1. By Value
    4. U.K.
      1. By Service Type
        1. Introduction
          1. Service Type By Value
        2. Bioanalytical Testing
          1. By Value
        3. Method Development and Validation
          1. By Value
        4. Stability Testing
          1. By Value
        5. Drug Substances Testing
          1. By Value
        6. Microbial Testing
          1. By Value
        7. Physical Characterization
          1. By Value
        8. Others
          1. By Value
      2. By End User
        1. Introduction
          1. End User By Value
        2. Medical Device Companies
          1. By Value
        3. Pharmaceutical & Biopharmaceutical Companies
          1. By Value
        4. Others
          1. By Value
    5. Germany
    6. France
    7. Spain
    8. Italy
    9. Russia
    10. Nordic
    11. Benelux
    12. Rest of Europe
    1. Introduction
    2. By Service Type
      1. Introduction
        1. Service Type By Value
      2. Bioanalytical Testing
        1. By Value
      3. Method Development and Validation
        1. By Value
      4. Stability Testing
        1. By Value
      5. Drug Substances Testing
        1. By Value
      6. Microbial Testing
        1. By Value
      7. Physical Characterization
        1. By Value
      8. Others
        1. By Value
    3. By End User
      1. Introduction
        1. End User By Value
      2. Medical Device Companies
        1. By Value
      3. Pharmaceutical & Biopharmaceutical Companies
        1. By Value
      4. Others
        1. By Value
    4. China
      1. By Service Type
        1. Introduction
          1. Service Type By Value
        2. Bioanalytical Testing
          1. By Value
        3. Method Development and Validation
          1. By Value
        4. Stability Testing
          1. By Value
        5. Drug Substances Testing
          1. By Value
        6. Microbial Testing
          1. By Value
        7. Physical Characterization
          1. By Value
        8. Others
          1. By Value
      2. By End User
        1. Introduction
          1. End User By Value
        2. Medical Device Companies
          1. By Value
        3. Pharmaceutical & Biopharmaceutical Companies
          1. By Value
        4. Others
          1. By Value
    5. Korea
    6. Japan
    7. India
    8. Australia
    9. Taiwan
    10. South East Asia
    11. Rest of Asia-Pacific
    1. Introduction
    2. By Service Type
      1. Introduction
        1. Service Type By Value
      2. Bioanalytical Testing
        1. By Value
      3. Method Development and Validation
        1. By Value
      4. Stability Testing
        1. By Value
      5. Drug Substances Testing
        1. By Value
      6. Microbial Testing
        1. By Value
      7. Physical Characterization
        1. By Value
      8. Others
        1. By Value
    3. By End User
      1. Introduction
        1. End User By Value
      2. Medical Device Companies
        1. By Value
      3. Pharmaceutical & Biopharmaceutical Companies
        1. By Value
      4. Others
        1. By Value
    4. UAE
      1. By Service Type
        1. Introduction
          1. Service Type By Value
        2. Bioanalytical Testing
          1. By Value
        3. Method Development and Validation
          1. By Value
        4. Stability Testing
          1. By Value
        5. Drug Substances Testing
          1. By Value
        6. Microbial Testing
          1. By Value
        7. Physical Characterization
          1. By Value
        8. Others
          1. By Value
      2. By End User
        1. Introduction
          1. End User By Value
        2. Medical Device Companies
          1. By Value
        3. Pharmaceutical & Biopharmaceutical Companies
          1. By Value
        4. Others
          1. By Value
    5. Turkey
    6. Saudi Arabia
    7. South Africa
    8. Egypt
    9. Nigeria
    10. Rest of MEA
    1. Introduction
    2. By Service Type
      1. Introduction
        1. Service Type By Value
      2. Bioanalytical Testing
        1. By Value
      3. Method Development and Validation
        1. By Value
      4. Stability Testing
        1. By Value
      5. Drug Substances Testing
        1. By Value
      6. Microbial Testing
        1. By Value
      7. Physical Characterization
        1. By Value
      8. Others
        1. By Value
    3. By End User
      1. Introduction
        1. End User By Value
      2. Medical Device Companies
        1. By Value
      3. Pharmaceutical & Biopharmaceutical Companies
        1. By Value
      4. Others
        1. By Value
    4. Brazil
      1. By Service Type
        1. Introduction
          1. Service Type By Value
        2. Bioanalytical Testing
          1. By Value
        3. Method Development and Validation
          1. By Value
        4. Stability Testing
          1. By Value
        5. Drug Substances Testing
          1. By Value
        6. Microbial Testing
          1. By Value
        7. Physical Characterization
          1. By Value
        8. Others
          1. By Value
      2. By End User
        1. Introduction
          1. End User By Value
        2. Medical Device Companies
          1. By Value
        3. Pharmaceutical & Biopharmaceutical Companies
          1. By Value
        4. Others
          1. By Value
    5. Mexico
    6. Argentina
    7. Chile
    8. Colombia
    9. Rest of LATAM
    1. Pharmaceutical Analytical Testing Market Share By Players
    2. M&A Agreements & Collaboration Analysis
    1. Eurofins Scientific
      1. Overview
      2. Business Information
      3. Revenue
      4. ASP
      5. SWOT Analysis
      6. Recent Developments
    2. SGS SA
    3. Charles River Laboratories
    4. Thermo Fisher Scientific Inc. (PPD)
    5. Intertek Group plc
    6. Pace Analytical Services, LLC
    7. WuXi AppTec
    8. Laboratory Corporation of America
    9. Almac Group
    10. Syneos Health
    11. ICON plc
    12. Exova Group plc
    13. Avomeen Analytical Services
    14. Element Materials Technology
    15. Toxikon Corporation
    1. Research Data
      1. Secondary Data
        1. Major secondary sources
        2. Key data from secondary sources
      2. Primary Data
        1. Key data from primary sources
        2. Breakdown of primaries
      3. Secondary And Primary Research
        1. Key industry insights
    2. Market Size Estimation
      1. Bottom-Up Approach
      2. Top-Down Approach
      3. Market Projection
    3. Research Assumptions
      1. Assumptions
    4. Limitations
    5. Risk Assessment
    1. Discussion Guide
    2. Customization Options
    3. Related Reports
  3. Disclaimer

Related Reports

Global Report
The global pharmaceutical glass tubing market size was valued at USD 14.79 billion in 2021. It is projected to reach USD 26.40 billion by 2030, growing at a CAGR of 6.65% during the forecast period (2022-2030) Pharmaceutical packaging businesses cre
Buy Now
Global Report
Pharmaceutical Packaging Market Size The global Pharmaceutical Packaging Market Size was valued at USD 162.77 billion in 2024 and is projected to reach from USD 178.07 billion in 2025 to USD 365.37 billion by 2033, growing at a CAGR of 9.4% during t
Buy Now
Global Report
The global pharmaceutical plastic bottles market size was valued at USD 8.49 billion in 2022. It is expected to reach USD 12.3 billion by 2031, growing at a CAGR of 4.21% during the forecast period (2023–2031). Pharmaceutical plastic bottles a
Buy Now

Purchase Benefits

  • Eligible for a free updated report next year
  • Completely customizable scope
  • 30% discount on your next purchase
  • Dedicated account manager
  • Query resolution within 24 hours
  • Permission to print the report

We are featured on :

www.straitsresearch.com
© Copyright 2025. All rights Reserved.